Skip to main content
. 2021 Feb 1;10(3):508. doi: 10.3390/jcm10030508

Figure 1.

Figure 1

CONSORT diagram of the ORTHO2 clinical trial. ON: Osteonecrosis; BM: Bone Marrow; IMP: Investigational Medical Product; hMSC: Human Mesenchymal Stems Cells (expanded).